Literature DB >> 22689102

Comparison of peripheral nerve damages according to glucose control timing in experimental diabetes.

H Y Jin1, S M Kang, W J Liu, C H Song, K A Lee, H S Baek, T S Park.   

Abstract

OBJECTIVE: In addition to tight glucose control, early intensive therapy has been reported to be more important for the prevention of diabetic micro- and macro-vascular complications. What is not known exactly is the quantitative difference according to timing delay in glucose control and whether early period control is really better than late control in terms of diabetic peripheral neuropathy. In this study, we investigated the effect of timing differences in glucose control on the peripheral nerves in an experimental diabetic model.
METHODS: 5 groups (6-8 rats in each group) were comprised of normal glucose rats (designated control), rats with hyperglycemia (designated DM), rats with glucose control for the entire 28-week study period (designated DM + INS [W0-28]), rats with glucose control for the early 14-week period followed by hyperglycemia for the late 14-week period (designated DM + INS [W0-14]), and rats with hyperglycemia for the early 14-week period followed by glucose control in the late 14-week period (designated DM + INS [W15-28]).
RESULTS: We found that the current perception threshold (CPT) was lower in the DM + INS (W0-28) and DM + INS (W15-28) groups than in the DM + INS (W0-14) or DM groups (P<0.05). The mean myelinated fiber area of the sciatic nerve was significantly greater in the DM + INS (W0-28) and DM + INS (W15-28) groups (63.5±2.32 and 60.1±2.14 um, respectively) than in the DM + INS (W0-14) or DM groups (55.5±2.81 or 51.5±2.64 um, respectively) (P<0.05), and the intraepidermal nerve fiber (IENF) density was significantly higher in the DM + INS (W0-28) and DM + INS (W15-28) groups (6.9±0.46 and 6.8±0.11, respectively) than in the DM + INS (W0-14) or DM groups (59.5±0.32 and 5.3±0.39/mm, respectively) (P<0.05).
CONCLUSION: Our results indicate that continuous glucose control is necessary to alleviate peripheral nerve damage and that glycemic control during the later period may be more important than early period management. The importance of continuous glucose control, including the later period of diabetes, should therefore be emphasized in diabetic peripheral neuropathy. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689102     DOI: 10.1055/s-0032-1306350

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  3 in total

1.  An early diagnostic tool for diabetic peripheral neuropathy in rats.

Authors:  Shoista Kambiz; Johan W van Neck; Saniye G Cosgun; Marit H N van Velzen; Joop A M J L Janssen; Naim Avazverdi; Steven E R Hovius; Erik T Walbeehm
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

2.  Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats.

Authors:  Kyung Ae Lee; Heung Yong Jin; Na Young Lee; Yu Ji Kim; Tae Sun Park
Journal:  Diabetes Metab J       Date:  2018-04-25       Impact factor: 5.376

3.  Influence of Glucose Fluctuation on Peripheral Nerve Damage in Streptozotocin-Induced Diabetic Rats.

Authors:  Yu Ji Kim; Na Young Lee; Kyung Ae Lee; Tae Sun Park; Heung Yong Jin
Journal:  Diabetes Metab J       Date:  2021-09-09       Impact factor: 5.376

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.